Exploring Equity in Diagnosis | Nov. 18-19, 2024 | Chicago, USA, and Online

About the Conference

AAIC® Advancements: Exploring Equity in Diagnosis aims to advance science and collaboration around identifying, understanding and addressing disparities in an era of biomarker-based diagnosis for Alzheimer’s disease and other dementias. This two-day conference will bring together leaders from across disciplines, including academia, industry, philanthropy and government.

As science advances and evolves, it’s critical that we understand and address how disparities play a role in dementia diagnosis. From ethics in diagnosis disclosure to issues of inequity within health systems, this meeting will address some of the big questions that come along with creating equity in diagnostic practices.

Research Themes

All are invited to submit abstracts and share research findings and key learnings about best practices, current and future challenges for equitable diagnosis of Alzheimer’s disease and related dementias.

Abstract themes will be aligned with the Health Disparities Framework and its four levels of analysis:

  • Behavioral Factors.
  • Environmental Factors.
  • Biological Factors.
  • Sociocultural Factors.

Read the full guidance for submitting an abstract (PDF).

Scientific Program Committee

Multiple Principal Investigators: Maria C. Carrillo, Gladys Maestre and Lycia Neumann.

  • Lisa Barnes, Chair
  • Amy Kind, Chair
  • Lycia Neumann, Chair
  • Stacy Carrington-Lawrence
  • Rebecca Edelmayer
  • Crystal Glover*
  • Carl V. Hill
  • Thomas K. Karikari
  • Damali Martin
  • Ozioma Okonkwo
  • Annalise M. Rahman-Filipiak
  • Luke Stoeckel
  • Astrid M. Suchy-Dicey
  • Keenan Walker
  • Whitney Wharton
  • Lisa Ann Kirk Wiese

*Ex-Officio Member

Sponsors

Companies interested in sponsoring AAIC Advancements: Exploring Equity in Diagnosis can contact the corporate initiatives team at corporateinitiatives@alz.org.

Appropriate Conduct Policy

AAIC Advancements: Exploring Equity in Diagnosis aims to provide a safe, equitable, and accessible experience for all conference participants.

Read the full Statement of Appropriate Conduct (PDF).

Contact

General questions: healthequity@alz.org
Media questions: media@alz.org

Conference Details

Dates: Nov. 18-19, 2024
Location: Swissotel Chicago, USA, and online
Cost:

  • In-person attendance: $50-$75 for ISTAART members, $150 for non-members.
  • Virtual attendance: Free for ISTAART members, $25 for non-members.

Register Now


Call for Abstracts

  • General abstract submission deadline: Sept. 13, 2024, at 11:59 p.m. Eastern Daylight Time (North America)
  • Extended ISTAART abstract submission deadline: Sept. 16, 2024, at 11:59 p.m. EDT

A limited number of conference fellowships are available. You can apply for a fellowship during the abstract submission process.

Submit an Abstract


Go Beyond the Conference

Network and collaborate year-round with ISTAART, a global community of scientists, clinicians and dementia professionals who are working to advance Alzheimer’s and dementia research and treatment.

Join ISTAART

Join the Conversation


#AAICAdvancements #ExploringEquity24

We use cookies to improve your experience on this website. Learn about options for managing your personal data in our Privacy Policy.